Home News Stock to Watch: Medidata Solutions (NASDAQ: MDSO)

Stock to Watch: Medidata Solutions (NASDAQ: MDSO)

SHARE

Medidata Solutions is in the technology sector and application software industry. The company CEO is Tarek A Sherif. Medidata Solutions Inc provides cloud-based solutions for life sciences. Its customers are pharmaceutical, biotechnology, and medical device companies, academic institutions, and contract research organizations.

Previous Intraday Trading Performance:

The MDSO stock showed a previous change of 1.57% with an open at 90.43 and a close of 90.68. It reached an intraday high of 90.92 and a low of 89.00.

Business Wire:  Medidata Institute Redefines Technology’s Role in Advancing Science and Healthcare

Liquidity:

The stock has a market cap of $5.6b with 62.3m shares outstanding, of which the float is 59.3m shares. Trading volume reached 582,541 shares compared to its average volume of 907,467 shares. Based on the current average volume and close price, the trading liquidity is good.

Historical Trading Performance:

Over the last five trading days, Medidata Solutions shares returned 1.43% and in the past 30 trading days it returned 3.41%. Over three months, it changed 22.08%. In one year it has changed 14.74% and within that year its 52-week high was 98.60 and its 52-week low was 60.10. MDSO stock is 50.88% above its 52 Week Low.

Our calculations show a 200 day moving average of 76.10 and a 50 day moving average of 85.04. Currently MDSO stock is trading 19.16% above its 200 day moving average.

Business Wire:  Medidata Institute Redefines Technology’s Role in Advancing Science and Healthcare

Earnings:

The last annual fiscal EPS for the company was reported at 0.84 that ended on 31st of December 2018, which according to the previous close, that is a PE of 107.95. Based on 7 analyst estimates, the consensus EPS for the next quarter is 0.11. The TTM EPS is 0.95, which comes to a TTM PE of 95.45. Historically, the PE high was 542.90 and the PE low was 73.60. If the stock reached its PE low, that would represent a price of 69.92, which is a decrease of -22.89%.

Below was the last reported quarterly diluted earnings per share:

1stQtr of 2019 (Reported on 04/30/2019): 0.18
4thQtr of 2018 (Reported on 02/12/2019): 0.23
3rdQtr of 2018 (Reported on 10/18/2018): 0.17
2ndQtr of 2018 (Reported on 07/24/2018): 0.27
1stQtr of 2018 (Reported on 04/19/2018): 0.17

Base on our calculations, the intrinsic value per share is 56.56, which means it may be overvalued by -60.34%.

Indicators to Watch:

The current calculated beta is 1.30.

SeekingAlpha:  Merger Arbitrage Mondays – April 1, 2019

Fundamental Indicators:

Based on last reported financials, the company’s return on equity is 9.48%, return on assets is 5.34%, profit margin is 8.04%, price-to-sales is 8.42 and price-to-book is 8.73.

Company Scores:

All scores are out of six:
 0  :Valuation Score
 1  :Past Performance Score
 6  :Financial Strength Score
 4  :Future Growth Score
 0  :Dividend Score
 2  :Overall Score

SHARE
John Jones
Worked for several Wall Street firms: Salomon Smith Barney, UBS, and Charles Schwab. Has developed skills and gained extensive experience over the years that is used today to uncover winning penny stocks.Also was an attorney for small businesses in Scottsdale, Arizona. That experience and understanding of law provides a unique perspective and edge in discovering quality companies in various industries.